Atmosphärische Deposition und Anreicherung von Schwermetallen und Stickstoff in Natura-2000-Gebieten Deutschlands

Purpose Under the Convention on Long-range Transboundary Air Pollution mosses are used to map the bioaccumulation of heavy metals and nitrogen throughout Europe. To this end, since 1990 mosses were sampled and analyzed chemically every five years. The goal of this article is to apply the moss survey data for assessing the bioaccumulation of Cd, Pb and N in German Natura 2000 Sites of Community Importance (SCI). Methods The temporal trends of the heavy metal bioaccumulation within SCIs were analyzed using a multi metal index (MMI) calculated by means of geostatistics and percentile statistics. For nitrogen, only monitoring values for 2005 were available for the assessment. The geostatistically estimated values of the metal and nitrogen concentrations in mosses were transformed to estimated deposition values by use of regression analyses. Subsequently, the results were integrated into the assessment of the German SCIs. Results Highest metal loads within SCIs were detected in 1990, followed by a continuous decrease to 2000 and a significant increase until 2005. Regarding N, a median of 1.5 % nitrogen in the dry mass was calculated. The deposition values calculated from the moss estimates resulted in median values of 0.33 g/ha/a for Cd, 8.2 g/ha/a for Pb and 16.7 kg/ha/a for nitrogen. Conclusions The Moss-Monitoring is the only environmental monitoring programme which enables statistically sound estimations of the exposure of SCI to environmental contaminants in terms of heavy metal and nitrogen deposition and bioaccumulation

Novel and shared neoantigen derived from histone 3 variant H3.3K27M mutation for glioma T cell therapy

The median overall survival for children with diffuse intrinsic pontine glioma (DIPG) is less than one year. The majority of diffuse midline gliomas, including more than 70% of DIPGs, harbor an amino acid substitution from lysine (K) to methionine (M) at position 27 of histone 3 variant 3 (H3.3). From a CD8(+) T cell clone established by stimulation of HLA-A2(+) CD8(+) T cells with synthetic peptide encompassing the H3.3K27M mutation, complementary DNA for T cell receptor (TCR) alpha- and beta-chains were cloned into a retroviral vector. TCR -transduced HLA-A2(+) T cells efficiently killed HLA-A2(+)H3.3K27M(+) glioma cells in an antigen- and HLA-specific manner. Adoptive transfer of TCR -transduced T cells significantly suppressed the progression of glioma xenografts in mice. Alanine-scanning assays suggested the absence of known human proteins sharing the key amino acid residues required for recognition by the TCR, suggesting that the TCR could be safely used in patients. These data provide us with a strong basis for developing T cell-based therapy targeting this shared neoepitope